HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bernard Hausen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hausen, B. Articles by Borst, H.-G. Search for Related Content PubMed PubMed Citation Articles by Hausen, B. Articles by Borst, H.-G.

J Thorac Cardiovasc Surg 1997;113:1050-1058
© 1997 Mosby, Inc.

CARDIAC AND PULMONARY REPLACEMENT

EXOGENOUS SURFACTANT TREATMENT BEFORE AND AFTER SIXTEEN HOURS OF ISCHEMIA IN EXPERIMENTAL LUNG TRANSPLANTATION

Received for publication May 6, 1996 revisions requested June 11, 1996; revisions received Dec. 12, 1996 accepted for publication Feb. 18, 1997. Address for reprints: Bernard Hausen, MD, Transplantation Immunology, Department of Cardiothoracic Surgery, Falk CVRB, Stanford University Medical Center, 300 Pasteur Dr., Stanford, CA 94304-5247.

Abstract

Objective: A syngeneic, acute, double lung transplant model in the rat was used to determine the impact of exogenous surfactant treatment on graft function after prolonged cold storage. Methods: The donor grafts were flush perfused, preserved for 16 hours, and then reperfused for 120 minutes. Untreated lungs served as controls (group I). In group II the recipient received a 200 mg/kg dose of surfactant (CuroSurf) before reperfusion. In groups III and IV, surfactant was administered before perfusion and harvesting (III, 20 mg/kg; IV, 200 mg/kg). Serial measurements of graft pulmonary vascular resistance, alveolar-arterial oxygen difference, and compliance were obtained. Final graft assessment included weight gain and histologic study. Results: Repeated-measures analysis of variance showed significant improvement of graft performance in respect to compliance, alveolar-arterial oxygen difference, and pulmonary vascular resistance in donor surfactant treatment group IV (200 mg/kg) in comparison with recipient treatment (group II) and untreated controls (group I). Reducing the donor surfactant supplementation from 200 mg/kg to 20 mg/kg (group III) improved oxygenation and lung compliance as compared with untreated controls. Grafts in groups I and II had significantly more weight gain after 2 hours of reperfusion. Recipient treatment resulted in significantly more pulmonary hemorrhage in histologic sections. Conclusion: Donor treatment with exogenous surfactant is advantageous for preservation of graft function after extended ischemia. Positive effects may be seen with as little as 20 mg/kg of exogenous surfactant given before donor organ perfusion.

This article has been cited by other articles:

				N. P. van der Kaaij, J. J. Haitsma, J. Kluin, B. N. Lambrecht, B. Lachmann, R. W.F. de Bruin, and A. J.J.C. Bogers Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 774 - 782. [Abstract] [Full Text] [PDF]

				I. Friedrich, J. Borgermann, F. H. Splittgerber, M. Brinkmann, J. C. Reidemeister, R. E. Silber, W. Seeger, R. Schmidt, and A. Gunther Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 335 - 343. [Abstract] [Full Text] [PDF]

				M. de Perrot, M. Liu, T. K. Waddell, and S. Keshavjee Ischemia-Reperfusion-induced Lung Injury Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 490 - 511. [Abstract] [Full Text] [PDF]

				M. de Perrot and S. Keshavjee Lung preservation Ann. Thorac. Surg., August 1, 2002; 74(2): 629 - 631. [Full Text] [PDF]

				J. M. HOHLFELD, E. TIRYAKI, H. HAMM, H. G. HOYMANN, N. KRUG, A. HAVERICH, and H. FABEL Pulmonary Surfactant Activity Is Impaired in Lung Transplant Recipients Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 706 - 712. [Abstract] [Full Text] [PDF]